Fundraising Fox
Nimble Therapeutics
Madison, US · Founded 2019 · Delaware corporation · 12 employees on LinkedIn · 1 known investors
Find your way into Nimble Therapeutics
Sign up to see every warm intro you have to Nimble Therapeutics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Nimble Therapeutics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
A biopharmaceutical company that discovers and develops medicines, building on immunology research to explore additional disease areas. The page content appears to redirect to AbbVie, and provides limited specific information about Nimble Therapeutics itself.
Founders & leadership
JP
Jigar PatelCEOJigar Patel is an executive in the biotechnology industry with experience in business development, drug discovery, and genomics. He serves as an executive officer and director at Nimble Therapeutics, a biopharmaceutical company developing immunology-based medicines.
Board
RH
DL
Investors · 1
Reported raises · per SEC filings
Form D private placements$10M disclosed across 1 round · 2019
▶$10MraisedApr 2019 · 3 investors · BiotechnologyRule 506(b)
▶$10MraisedApr 2019 · 3 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Jigar PatelExecutive Officer, Director
- Rob HartDirector
- Deval LashkariDirector
- Offering amount
- $10M
- Amount sold
- $10M
- First sale
- Apr 2019
- Incorporated
- Corporation, Delaware, 2019
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- What does Nimble Therapeutics do?
- A biopharmaceutical company that discovers and develops medicines, building on immunology research to explore additional disease areas. The page content appears to redirect to AbbVie, and provides limited specific information about Nimble Therapeutics itself.
- Who are Nimble Therapeutics's investors?
- Nimble Therapeutics's investors include Telegraph Hill Partners.
- How much funding has Nimble Therapeutics raised?
- Nimble Therapeutics has disclosed $10M raised across 1 round.
- Where is Nimble Therapeutics headquartered?
- Nimble Therapeutics is headquartered in Madison, US.